[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2013/02/gimlet-eye.jpg” thumb_width=”150″ /]Care Innovations‘ recent (undated) press release (discovered as a LinkedIn update), if read without a Gimlet Eye, could be read as another one of those ‘good news’ releases that build company awareness and get it picked up on websites such as TTA. Certainly there’s a nice spin of positive news for remote monitoring technologies, particularly more complex ones in vital signs monitoring and broadening out their applicability. (More on those below.) But the observant eye will pick out a couple of ‘aha!’ moments at this company that got slipped in, but not slipped by, the Eye.
The first is that GE has departed the building. Always the junior partner except for the very beginning in 2009, GE apparently exited sometime after December based on the last press release with Intel-GE identification issued 1 Dec 2015. The boilerplate company description is no longer ‘Intel-GE Care Innovations’ but now ‘Care Innovations, a wholly-owned subsidiary of Intel Corporation’. Lift your eyes to the company logo at the top left of the web page, and there it is, ‘An Intel Company’. GE is not fully cleansed, still to be found on product pages such as Health Harmony and QuietCare, as well as the copyright line at the bottom of each web page. (More work to be done)
The second is the appearance of CI’s new CEO, Randy Swanson, in the executive quote and on the ‘team’ website page. His bio notes that he’s a 17-year Intel finance/business development veteran, at one point with responsibilities in the Digital Health Group. Tea leaf readers might well surmise that Intel will now emphasize profitability at CI after the major repositioning and partner expansion during the 2.5 years of Sean Slovenski’s tenure (a non-Intel’er departed in January to Healthways, TTA 13 Jan).
The release also has a few more interesting moments. Care Innovations claims their ‘strongest year in 2015 since the inception of the company in 2009’, including its new partnership with large home health company Amedisys and its research partnership with University of Mississippi Medical Center (UMMC) to extend RPM to new areas such as maternal care and organ donation. Then the release, instead of the usual expansion of the above, lurches into stats on RFPs (request for proposals) as up 300 percent and in new ground such the organ donation support. RFPs are a weak claim at best to reinforce your main growth story and tend to beg the question as to how many, really. Example: if there was one RFP prior year and now there are three, that is…300 percent. After this diversion, it marches into the executive quote, expands on Amedisys, UMMC and introduces the US Congressional CONNECT legislation expanding telehealth in Medicare [TTA 12 Feb] as the reinforcement wrap.
Surely, more to come. Comments welcome. Hat tip to reader Geoff Clapp.